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Abstract
The World Health Organization recommends exclusive breastfeeding (EBF) for the first 6 months after birth. The deu-
terium oxide dose-to-the-mother (DTM) technique is used to distinguish EBF based on a cut-off (\ 25 g/day) of water
intake from sources other than breastmilk. This value is based on a theoretical threshold and has not been verified in field
studies. The aim of this study was to estimate the water intake cut-off value that can be used to define EBF practice. One
hundred and twenty-one healthy infants, aged 2.5–5.5 months who were deemed to be EBF were recruited. After
administration of deuterium to the mothers, saliva was sampled from mother and infant pairs over a 14-day period.
Validation of infant feeding practices was conducted via home observation over six non-consecutive days with caregiver
recall. A fully Bayesian framework using a gradient-based Markov chain Monte Carlo approach implemented in Stan was
used to estimate the cut-off of non-milk water intake of EBF infants. From the original data set, 113 infants were
determined to be EBF and provided 1500 paired mother–infant observations. The deuterium saliva concentrations were
best described by two linked 1-compartment models (mother and infant), with body weight as a covariate on the mother’s
volume of distribution and infant’s body weight on infant’s water clearance rate. The cut-off value was based on the 90th
percentile of the posterior distribution of non-milk water intake and was 86.6 g/day. This cut-off value can be used in
future field studies in other geographic regions to determine exclusivity of breast feeding practices in order to determine
their potential public health needs.
Keywords Human milk  Breastfeeding  Deuterium-oxide turnover method  Pharmacokinetics  Bayesian 
MCMC  Stan
Introduction
Optimal breastfeeding practices during early infancy
reduce morbidity and mortality, and improve infant
growth, health and development [1]. Exclusive breast-
feeding (EBF) up to 6 months of age is one of the optimal
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breastfeeding practices recommended by the World Health
Organization. EBF is defined as the practice of giving an
infant only breastmilk (no other food or water). After
6 months of age the addition of appropriate complementary
foods to ongoing breastfeeding is recommended for up to 2
years or beyond [2]. However, despite the well-established
benefits of breastfeeding, global rates remain below inter-
national targets [3]. Efforts to increase the prevalence of
EBF have yielded varying results due, at least in part, to the
various methods used to evaluate exclusivity. Estimates of
EBF are often based on caregiver recall over a single
period 24-h period, or in some cases maternal recall for the
whole period of breastfeeding since birth. The validity of
these recall methods has been questioned with concerns
about EBF rates being overestimated in a population due to
self-reporting bias [4, 5], especially in the face of programs
delivering intensive behaviour change communication on
breastfeeding to mothers [6]. In addition, the 24-h recall
method does not capture infants who are given food or
drink on days preceding the recall period. Several studies
have identified significant levels of misreporting among
varying population groups when recall methods are com-
pared to a method based on a dose-to-mother (DTM)
deuterium oxide dilution (D2O) technique [7–10].
The D2O dilution DTM method [11] provides an esti-
mate of infant water intake from breastmilk which then
allows any additional water ingestion from non-breastmilk
sources to be determined. In this technique, deuterium
oxide is given orally to the mother. The D2O disperses
uniformly throughout the body water pool within a few
hours and transferred to her infant through lactation. The
disappearance of the isotope from the mother and the infant
(sampled from saliva, urine or milk) is monitored over a
14-day period. A standard compartmental model is used to
provide a description of the data [11]. Essentially, this
method requires back calculation of the likely infant dose
from non-breastmilk sources once other sources of input
and loss have been accounted. Since it is impossible to
accurately account for all non-breastmilk sources using the
DTM (or indeed any) method then a cut-off value for the
non-breastmilk water source is required. Moore et al. [7]
recommended a value of 24.6 g/day of water intake from
non-breastmilk sources based on maternal self-reported
breastfeeding practices. Individual mother–infant pairs
with values lower than this cut-off criterion are determined
to be EBF and values above this cut-off as non-EBF. This
value has yet to be verified in mother–infant pairs.
This investigation work presented here, is concerned
with modelling deuterium exposure in mother–infant pairs
and determining the cut-off criterion for determining EBF.
The aims of this study were to: (i) develop a population
pharmacokinetic model to estimate the apparent volume of
non-milk water intake in mother–infant pairs using the D2O
DTM technique, and (ii) identify a cut-off value of non-
milk water intake that is compatible with EBF. In this work
a fully Bayesian technique is used in order to enumerate
uncertainty in both the model parameters and also the
assumptions inherent in the use of the standard compart-
mental model.
Methods
This section is divided into five sections: (1) the data used
in this study; (2) identification of an appropriate structural
model to describe the breastfeeding mass transfer of D2O;
(3) specification of statistical models for the priors and
constants; (4) model development, and (5) determination of
an appropriate criterion for non-milk fluid intake to define
exclusivity of breastfeeding. Components 1–4 correspond
to aim (i) and component 5 to aim (ii).
All modelling was performed within a fully Bayesian
framework using Stan (v 2.12.0) via the rstan (Version
2.11.1) interface, compiled on C ?? (GCC 4.6.3) and run
with R (version 3.3.1). Details of the Stan method are
provided in [12]. In brief, Stan is a Monte Carlo sampling
algorithm that uses a No-U-Turn sampler (NUTS) to build
a set of likely candidate points that spans the target dis-
tribution. The algorithm stops automatically when it starts
to double back and retrace its steps. Empirically, the NUTS
algorithm performs at least as efficiently, and sometimes
more efficiently than a well-tuned standard Hamiltonian
Monte Carlo method, without requiring user intervention or
costly tuning runs [13]. These methods, similar to Gibbs
and Metropolis–Hastings sampling, generate Markov
chains that fall within the overall group of Markov chain
Monte Carlo (MCMC) techniques which are used to make
inferences about the posterior distribution of the parame-
ter(s) in question. Some examples of Bayesian analysis
include Lunn et al. [14], Duffull et al. [15], Wendling et al.
[16] and Wendling et al. [17] for a review.
A full analysis plan was developed outlining the analysis
components below, and summarised briefly in this section.
Data
A calibration study was conducted in Tanjunsari, Sukasari
and Pamulihan, subdistricts of Sumedang in the province of
West Java, Indonesia. A total of 121 mother–infant pairs
were recruited. Infant inclusion criteria included being a
singleton, full term ([ 37 weeks gestation) with a birth
weight[ 2500 g. At the time of enrolment, infants were
aged 2.0–5.5 months old, had been identified as EBF and
had no identified medical problems, e.g. active tuberculo-
sis, severe anaemia (i.e., haemoglobin [\ 90 g/L]) or acute
malnutrition (i.e. mid-upper arm circumference less than
2 Journal of Pharmacokinetics and Pharmacodynamics (2019) 46:1–13
123
115 mm). Written informed consent was obtained from all
participating mothers. Ethical approval for the study was
granted by University of Otago Human Research Ethics
Committee New Zealand (H15/125) and the Health
Research Ethics Committee Faculty of Medicine Univer-
sitas Padjadjaran, Bandung (081), Indonesia.
Pre-dose baseline saliva samples were obtained from the
mother and infant on day 0, after which each mother
received orally * 30 g deuterium oxide (accurately mea-
sured to the nearest 0.01 g) and diluted in* 50 g drinking
water. Saliva samples (* 2 mL) were collected by placing
small sterile cotton balls in the mouths of the mothers and
infants for a few minutes, after which the saliva was
expressed from the wet cotton ball using a disposable
syringe. Post-dose saliva samples were collected from the
mother and infant on days 1, 2, 5, 6, 13 and 14. Duplicate
saliva samples (two taken within 1 h; around 30 min) were
collected on day 0, either day 5 or 6, and day 14. The
duplicate samples were treated as replicate measures and
the mean of the two sampling times and saliva concentra-
tions were used in the analysis. The rationale for this
approach is presented in Supplement 1. After collection, all
saliva samples were centrifuged at 3500 r.p.m. and then
stored at - 20 C prior to analysis. The enrichment of
deuterium in saliva samples was measured using Fourier
transform infrared spectrometry (FTIR). The limit of
quantitation for saliva samples is 20 mg/kg and the limit of
detection for saliva samples is 6 mg/kg. The day-to-day
(inter-day) and intra-day coefficient of variations (CV%) of
measurements are similar to each other with the value of
0.5%.
Mothers were instructed to continue exclusively
breastfeeding their infants over the 14-day collection per-
iod. In all cases direct observation of feeding practises in
the home were performed by trained field assistants who
were known and trusted by the mothers and were recruited
from the local community. Field assistants were trained to
observe the mother–infant pairs in their own homes from
6.00 am until at least 6.00 pm each day to ensure a max-
imum 12-h observation on three non-consecutive days per
week (6 days total) over the 14 day full DTM protocol
period. During this 12-h observation period, field assistants
recorded, in a diary, the time and duration of each breast-
feeding episode and classified each breastfeeding practise
as EBF and non-EBF according to the operational defini-
tions [18]. Night-time breastfeeding practises for each 12-h
period preceding each observation day were assessed by
maternal recall. Unannounced spot-checks were also made
by the field assistants on the non-observation days.
Structural model
The structure model used in this study is a two linked
1-compartment disposition models that represent mother
and infant as in Fig. 1. The model is equivalent to those
that have been applied previously [11, 25, 27, 28]. Details
of the model derivation and assumptions are presented in
Supplement 2.
We note that the rate constants kmb and kbo in Eqs. (1)
and (2) for D2O are identical to H2O due to that D2O has
the same disposition kinetics as H2O, and therefore,
kbo ¼ kboðH2OÞ ¼
CLbo
Vb
ð1Þ
kmb ¼ kmbðH2OÞ ¼
CLmb
Vm
ð2Þ
and CLbo is the H2O clearance rate from infant (units:
L/day); CLmb is the H2O clearance rate from mother to
infant (units: L/day); Vb is the D2O volume of distribution
in infant compartment (units: L); and Vm is the D2O vol-
ume of distribution in mother compartment (units: L). Note
here a density of dilute heavy water to be the same as water
(= 1.0 kg/L) was applied. The term CLmo in Fig. 1 is the
difference of the total clearance from the mother (CLmm)
and the mothers clearance to the infant and is hence given
by CLmm  CLmb. Of note, CLmm is replaced by kmmVm in
the model and kmm is defined next.
The system expressed as rate constants (for simplicity)
is given:
Vm
Mother D2O
Vb
Infant D2O
CLmo
CLbo
CLmb
D
2
O dose
Fig. 1 D2O disposition model for mother and infant. The term V
denotes the D2O volume of distribution with subscript m and b for
mother and infant; CLmb is the water clearance from mother to infant;
CLbo is the water clearance from infant to out; the term CLmo
represents the water clearance from mother to out
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dAm=dt ¼ ðkmm  kmbÞAm  kmbAm ¼ kmmAm ðat t
¼ 0; Am ¼ doseÞ ð3Þ
dAb=dt ¼ kmbAm  kboAb ðat t ¼ 0; Ab ¼ 0Þ ð4Þ
The analytical solutions of Eqs. (3) and (4) are:
AmðtÞ ¼ Amð0Þekmmt ð5Þ
AbðtÞ ¼ Amð0Þ kmb
kmm  kbo
 
ðekbot  ekmmtÞ ð6Þ
In this notation, AmðtÞ is the mass of D2O in mother
compartment at time t (units: kg); Amð0Þ is equal to dose
(units: kg); AbðtÞ is the mass of D2O in infant compartment
at time t (units: kg); kmm is the rate constant, describing
D2O total elimination from the mother compartment (units:
1/day); kmb is the rate constant describing D2O flow from
the mother to the infant via lactation route (units: 1/day);
kbo is the rate constant describing D2O flow out of the
infant compartment (units: 1/day). Notice that the notation
kmm, is the total D2O flow rate constant from the mother,
including the exit routes by lactation, urine, breath and skin
evaporation.
In this study the concentration of D2O is measured, not
the mass of D2O in the body, therefore Eqs. (3) and (4) are
required to be scaled to concentration. In order to scale the
amounts to concentrations an assessment of hydration
status was conducted by the field investigator for both
mother and child. In the absence of changes in status the
mother’s volume of distribution is expected to be constant
over the 14 days of the study. The infant’s volume of
distribution (Vb), however, will change (usually increasing
due to infant growth) during the study period. Growth of
the infant’s volume of distribution over this period can be
determined by the change in infant weight [given by
Eqs. (A1.8) and (A1.9) in Appendix 1].
In this work, either the fraction of D2O that crosses via
breastmilk and into the infant or the volume of distribution
of the infant is not identifiable. Since the fraction and
therefore quantity of water ingested by the infant during
breastfeeding is the focus of this work it is therefore nec-
essary to assume a value of Vb for all infants based on a
reference covariate such as weight or height. Based on
prior work the volume has been assumed to be a function of
weight [25], or the combination of weight and height [26].
This is addressed in Eq. (A1.9) in Appendix 1.
The final model consists of four parameters kmm,Vm,
CLmb and CLbo. Of these, the parameters CLmb and CLbo
are of primary importance to determine the non-breastmilk
water intake.
Statistical models
A standard three-stage hierarchical model was used. (Stage
1) the model for the data; (Stage 2) the model for hetero-
geneity between individuals; (Stage 3) the model for the
priors. An additional part is also presented here about the
statistical models to calculate Rs.
Stage 1: model for the data
yijNðf hi; xij
 
; r2Þ ð7Þ
where yij denotes the jth observation for the ith subject,
f hi; xij
 
is the expected value of the data from the model
prediction, hi is a vector (dimension p 1, where p is the
number of parameters) of individual parameter values for
the ith individual, xij is a sampling time (and other design
variables such as dose), N represents a normal distribution
with (in this case) zero mean and standard deviation r.
Stage 2: model for heterogeneity between individuals
The distribution of an individuals’ PK parameter vectors hi
are shown,
lnðhiÞNpðlnðlÞ;XÞ; and ð8Þ
XQpðq;VÞ ð9Þ
where l is a vector of mean population pharmacokinetic
parameters and X is the variance–covariance matrix of
between subject random variability. Np represents a p-di-
mensional multivariate normal distribution.
Qp is the quadratic form using the column vector V as a
diagonal matrix, q is the LKJ correlation matrix, generating
random correlation matrices based on vines and extended
onion method [29]. Qp is equivalent with the calculation
result of VqV (where V is diagonal), which provides the
variance–covariance matrix for the fitted parameters. A
detailed description about q and V can be found in [12].
Stage 3: model for the priors
Priors for the analysis include: (1) priors for the parameters
and, (2) priors for the known variables. In this work there
are a number of known variables, that are usually consid-
ered to be constants in other work (for instance, the prior
model for milk composition). In this work, they are con-
sidered as random variables with a known mean and
variance.
The prior of the residual variance is:
rNð0; 1000Þ with r[ 0 ð10Þ
Here r is sampled from a truncated normal distribution.
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The prior for the vector of mean parameters, in this
study, l, i.e. CLmb, CLbo, kmm, and Vm, is given by a low
information prior was assumed for all:
lnðlÞNð0; 1000Þ ð11Þ
The priors of the variance–covariance matrix
XQpðq;VÞ is:
q lkj corrð1Þ ð12Þ
kiNð0; 1000Þ with ki[ 0; and V ¼ kIp ð13Þ
Here Ip represents a p p identity matrix, the parameter
‘‘1’’ in the lkj corr function is the shape parameter. In this
case ‘‘1’’ represents a bounded uniform distribution on the
space of correlations, and V is from a truncated normal
distribution.
Statistical models to calculate Rs
The primary objective of this study is to determine whether
the mother is exclusively breastfeeding her infant. The
ingested water intake rate from sources other than breast-
milk (denoted Rs) is used as the metric to describe quan-
titatively the exclusivity of breastfeeding and a criterion
value of this metric will be determined from this study
from which EBF and non-EBF characteristics of this and
future populations can be evaluated. This is a natural and
appropriate choice since if the ingested water intake rate
from other sources is zero, it indicates absolute EBF, i.e.
the only ingested water source for the infant is from
breastmilk. The model development process of calculating
Rs are outlined, and the relevant assumptions are described
in Appendix 1.
It should be noted that the purpose of this study is to
provide the best estimate of parameters at individual level
(e.g. Rs, CLmb and CLbo etc.) and the parameters at popu-
lation do not hold a particular significance.
Model development
Model selection
Model selection was based on two criteria, Watanabe-
Akaike information criterion (WAIC) and Leave One Out
(LOO) Cross Validation. Individual subject Visual Predict
Checks (iVPCs) were also used to evaluate the model. For
the iVPCs all individual posterior samples (pooled across
all chains) minus the burn-in samples were used.
The WAIC was defined as:
WAIC ¼ 2
XNi
j¼1
Xn
i¼1
log
1
s
XS
s¼1
p yi;j;sjhi;s
  !þ 2pWAIC;
ð14Þ
where Ni is the number of observations for subject i, n is
the number of subjects; yi;j;s is the sth sample of the jth
observation for the ith subject; hi;s is the sth sampled
parameter for individual i and S is the number of samples.
The first term on the right hand side of the equation is
equivalent to the log density of the data, in - 2log(likeli-
hood) form and the second term 2pWAIC represents a
correction for the effective number of parameters to adjust
for overfitting. To estimate the term 2pWAIC, the method
[37] computes the posterior variance of the log predictive
density for each data point. Summing over all the data
points gives the effective number of parameters as,
pWAIC ¼
XNi
j¼1
Xn
i¼1
VSs¼1ðlogpðyi;j;sjhi;sÞÞ ð15Þ
Essentially WAIC is an extension of the Deviance
Information Criteria (DIC). The DIC criteria is calculated
at a point estimate of the parameters and may be unsta-
ble and slow to converge [38, 39]. Instead, WAIC is fully
Bayesian and is based on computation over the full
posterior.
LOO Cross Validation was also used in this study to
evaluate the model performance. Vehtari et al. [40] pro-
posed to use Pareto Smoothed Importance Sampling
(PSIS), a new approach to compute LOO using importance
weights. PSIS was used in this study since it has two
advantages. First it provides additional stability on the
calculation of LOO. Second, PSIS is able to approximate
LOO with the already available posterior distributions from
the full data which saves the computational time.
Bayesian analysis settings
Models were parameterized in terms of the natural log of
the parameters values [41] (e.g. ln(CL), ln(V)). In the
present study, three MCMC chains were run simultane-
ously. Each MCMC chain was run for 10,000 samples
(excluding the 1000 samples that were discarded during the
burn-in phase). The three MCMC chains were pooled to
represent the posterior distributions of the parameter values
of interest.
Model evaluation
The initial estimates of all the chains were selected by Stan
randomly. Convergence of the MCMC chains were asses-
sed using the potential scale reduction factor, Rhat (a
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measure of the ratio of between and within chain vari-
ability). All MCMC chains were assumed to have reached
the stationary distribution if Rhat values were close to 1.0
for all parameters [42]. Furthermore, the trace history of
MCMC samples for all chains were examined visually for
all parameters, in which a ‘fuzzy caterpillar’ [15] suggests
that MCMC chains had reached a stationary distribution. In
addition, the number of effective samples in a chain
‘‘n_eff’’ [43] was used to investigate the sampling effi-
ciency (i.e. the number of independent samples) during the
analysis for computation of summary measures. In addi-
tion, visual predictive checks based upon individual
mother–infant pair observations were available for
evaluation.
The criterion for the cut-off value of Rs relating
to EBF
The cut-off value of Rs (water intake from non-breastmilk
sources) to distinguish EBF and non-EBF was determined
on the basis of the pooled individual posterior distributions
of Rs. In the first step the individual posterior distributions
of Rs were determined for each mother–infant pair. Then
the Rs values for each study pair were pooled over all
mother–infant pairs from the calibration data set to form a
mixture distribution which was normalised by the total
number of samples to yield a population density of Rs.
The cut-off value was elicited a priori based on expert
opinion (AD, CS, TP, RG and LH). In this process the
investigators indicated that they expected about 90% of the
participants in the calibration study would have been
exclusively breastfed, even given the rigorous field study
techniques that were used. The cut-off value of the popu-
lation density of Rs was therefore set at 0.9 (i.e. the crite-
rion yields 90% of the total area under the mixture
distribution curve).
Results
Data
There were 121 mother–infant pairs recruited into this
study. Seven pairs were identified by the field assistants
during the study period as non-EBF due to the intake of
water from a source other than breastmilk and were
removed from further analysis. Consequently, the calibra-
tion data set consisted of 114 subjects with 1516
observations.
In this study, it is considered that data that arose from a
mother–infant pair to be biologically implausible pair if
CLbo[ 40% of infant body weight. For example, for a
5 kg infant the total water content would be about 3 kg and
hence a value of water clearance of 2.0 kg/day is biologi-
cally incompatible with life. This exception resulted in one
further mother–infant pair to be removed from the analysis.
Ultimately, there were a total of 113 EBF mother–infant
pairs with 1500 observations in the analysis. The demo-
graphics of the mother–infant pairs is presented in Table 1.
Final model
Different error models and covariates were tested and the
model performance were evaluated quantitatively and
graphically. The combined error model, mother’s weight
on her volume of distribution (Vm) in Eq. (16) and baby’s
weight on the clearance rate (CLbo) in Eq. (17) were
selected to be the full model (i.e. the best final model)
because, (1) The combined error model was statistically
preferred to the additive error model according to the
WAIC and LOO values as the item (2) in Supplement 3,
Table S3.1; (2) addition of mother’s weight on Vm; baby’s
weight on CLbo also agree with the marginal correlations
(see Supplement 3 Figs. S3.1 and S3.2) and also according
to the biological plausibility. The covariate relationships
were given by:
ln Vm;i
  ¼ Nð3:49; 0:07Þ þ Nð0:62; 0:04Þ lnMWTi
70 kg
ð16Þ
ln CLbo;i
  ¼ Nð0:16; 0:17Þ þ Nð0:17; 0:03Þ ln BWTi
5 kg
ð17Þ
where N is normal distribution with the distribution mean
and standard deviation; MWT is mother’s weight; BWT is
baby’s weight. 70 and 5 kg are the median value of
mother’s and infant’s weights respectively. i is the ith
individual.
The details of the structural, error and covariate models
are presented in the Stan code in Supplement 4.
Table 1 Summary statistics of the mother–infant pairs included in the
calibration study
Variable Median (range)
Mother–infant pair no. 113
Dose (g) 30.0 (30.0–30.2)
Baby age (month) 3.3 (2.0–5.4)
Baby WT start (kg) 5.9 (3.9–8.4)
Baby WT end (kg) 6.2 (4.3–8.5)
Baby gender 54 (m)/59 (f)
Mother age (year) 25 (16–42)
Mother WT (kg) 53.1 (34.5–93.1)
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Parameter estimates and diagnostics
for the fitting process
The mean and 95th percent credible interval of each indi-
vidual’s posterior distributions of the parameter values
(kmm,Vm, CLmb and CLbo) and the calculated posterior
distribution of Rs are provided in Supplement 5. The
population values of these parameters (i.e. population mean
and between subject variability) are presented in Supple-
ment 6. Sufficient samples need to be available from the
pooled population posterior distribution of Rs to ensure an
accurate description of the 90th percentile in order to define
the cut-off value for EBF. The sampling chains were
superimposed and appeared to be well mixed, and the Rhat
values were close to 1.0, indicating that a stationary solu-
tion was found. iVPC graphics for each mother–infant pair
were plotted to evaluate the final model performance.
iVPCs for all the pairs showed that the model describes the
observations satisfactorily and four (2 later classified as
EBF and 2 non-EBF) representative graphics are presented
in Fig. 2.
A mother–infant pair can then be determined as EBF (or
non-EBF) based on their posterior distribution of Rs, in
combination with the Rs cut-off value determined below.
Rs cut-off value
The final model was used to determine the pooled posterior
distribution of Rs over all mother–infant pairs. The indi-
vidual posterior densities are shown in Fig. 3 and the
pooled density in Fig. 4. The Rs cut-off value, determined
as the 90th percentile of the pooled posterior distribution,
was 86.6 g/day. This is similar to the value calculated from
base model (the model without covariates) of 84.6 g/day.
Discussion
In this work a hierarchical model describing the kinetics of
deuterium in mother–infant pairs was described. This
model included uncertainty in the population parameters
(at the prior level) as well as uncertainty in the constants
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Fig. 2 Individual Visual Predictive Checks for model evaluation.
Open circles are the observations. The solid lines represent the
median, 2.5% and 97.5% quantiles of the posterior distribution of the
model predicted response. The upper curves represent the mother and
lower curves the infant. ID = 25 and 39 are later classified as EBF.
ID = 1 and 12 are later classified as non-EBF
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that were not able to be estimated from the available data.
The final model showed that the concentration–time pro-
files could be estimated with acceptable accuracy. From
this it was possible to determine a value of Rs (infant water
intake (g/day) from non-milk sources) that could be used as
a criterion for classification of the practice of mother–in-
fant pairs as exclusively or non-exclusively breastfeed.
In this study, the mothers were instructed to maintain
EBF practice and more importantly, were monitored by
field assistants. To our knowledge, this is the first study that
has used a direct and objective monitoring method to assess
the mother’s breastfeeding practice. These rigorous field
study techniques are likely to be superior to the tradition-
ally used methods (e.g. caregiver recall) which are sub-
jective and may be biased [9]. It is believed therefore, that
the recruited mother–infant pairs in this study could be
considered as representative of best EBF practice. However
it is expected even in this best-practice population that
some mother–infant pairs may not have been perfectly EBF
and therefore, based on expert opinion, the cut-off criterion
was based on the belief that 90% of samples of Rs were
likely to be EBF. Hence it is possible that our EBF cut-off
criteria may be conservative and the actual cut-off value
being greater than 86.6 g/day. However, it is noted that our
cut-off value of Rs of 86.6 g/day is considerably higher
than previously suggested at 10–25 g/day. In order to
assess the relevance of the previous value in relation to the
experimental design used for DTM studies a theoretical
lower limit of the value of Rs was calculated. This lower
limit was determined as the 95% upper bound of the
M
ot
he
r -
In
fa
nt
 ID
Rs (g/day)
Rs cut off (86.6 g/day)
0 100
Fig. 3 The individual posterior densities of Rs and the Rs cut-off
value (at 86.6 g/day). Black dot is the mean of individual Rs posterior
distribution. Thick red line is the 25 and 75% quantiles and thin black
line is the 2.5 and 97.5% quantiles (Color figure online)
Fig. 4 The pooled probability
density function of Rs and the
identified cut-off value
distinguishing EBF and non-
EBF
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posterior distribution of Rs for a mother–infant pair where
the mother was a theoretical perfect EBF (i.e. where the
true Rs was set to zero). The posterior distribution in this
case accounts for the uncertainty in the parameter values
and fixed constants associated with DTM analysis tech-
nique recommended by IAEA, International Atomic
Energy Agency [11]. The cut-off value was determined to
be 56 g/day (see Supplement 7 for relevant calculations).
An interpretation of this value would indicate that it is
impossible to distinguish 56 g/day from 0 g/day by using
the D2O DTM technique irrespective of how rigorous the
field experiment or how fastidious the mother. The Rs cut-
off (86.6 g/day) identified in this work was interpreted as
the sum of the theoretical Rs lowest limit (56 g/day) and
experimental error introduced in the field work that prop-
agates into the analysis. In the work of Haisma et al. [25],
the mean EBF Rs value was reported as 10 g/day. Moore
et al. [7] reported the Rs distribution in their EBF group as
24.6 ± 62.1 g/day (with 24.6 g/day as the cut-off value).
We believe this value of Rs is essentially impossible
replicate in any DTM field study and would result in almost
all mother–infant pairs as non-EBF despite their best
practice.
The purpose of applying a full MCMC approach in this
work was to allow full enumeration of the uncertainty in
the parameters of the kinetic model that accounts for
uncertainty in all unknown ‘‘constants’’. From these pos-
terior distributions the distribution region of normal deu-
terium exposure in mother–infant pairs related to EBF (i.e.
Rs posterior distribution) was computed, and the Rs cut-off
criterion distinguishing EBF from non-EBF was also
determined. By using this criterion in combination with the
Rs posterior distribution, rather than assign a new mother–
infant pair as EBF or non-EBF their posterior probability
that the pair were EBF can be computed and estimation for
uncertainty and subjectivity in the inference from future
field studies is possible.
Even though attempts were made to account for uncer-
tainty in the many constants that contribute to the D2O
DTM approach, it is difficult to accommodate fully for
these error sources. For estimation of the Rs posterior
distribution to assess the EBF practice, appropriate calcu-
lation of the water through atmospheric water absorption
(i.e. Ra) is necessary. In this work, it is assumed that 6.3%
(SE 1.7%) of the total water input was from the atmo-
spheric water absorption. This value was based upon the
experiment conducted in Cambridge, UK [26]. However,
the mother–infant pairs and the experiment conducted in
our study were in Sumedang, Indonesia. The climate in
these two regions differ significantly, in terms of temper-
ature, moisture etc. (e.g. a range of ambient temperature in
Cambridge, 4–18 C and in Sumedang, 28–31 C). It is
speculated that the atmospheric water absorption
percentage in Indonesia differs from the UK. This differ-
ence might cause a noticeable change in the final Rs cut-off
value. Due to the unavailability of the atmospheric water
absorption percentage in Indonesia, it was assumed that the
percentage in the UK is also applicable in our study. More
generally speaking, the Rs cut-off value is likely to be
geographically and climatically dependent, meaning, dif-
ferent regions might have different Rs cut-off values based
upon the local climates. It is however evident that deter-
mination of Rs cut-off value in different regions could be
challenging. On the other hand, the ultimate goal of this
study is to categorize the new mother–infant pairs into EBF
or non-EBF groups based on the determined Rs cut-off
value and promote those non-EBF mothers to EBF. It is
believed that part of the inflation of our Rs cut off at
86.6 g/day (over and above the theoretical 56 g/day) will
reflect systematic bias in its estimate due to Ra and possibly
other factors. We do not believe that this will result in
misclassification of mother–infant pairs in similarly humid
regions but perhaps this cut-off may be less conservative in
more temperate regions.
The Rs cut-off value was determined based on expert
opinion that 90% of the participants in the calibration study
had been exclusively breastfed and accordingly the cut-off
value yields 90% of the total area under the probability
density curve. The value of 90% reflects of the confidence
about all the recruited mother–infant pairs being EBF,
which is ultimately a subjective judgement. On the other
hand, the judgement was supported by the rigorous field
study techniques that were used (e.g. the direct monitoring
methods). The application of these techniques is more
superior and reliable than, e.g. the biased caregiver recall
method.
It is intended that this work is used to help low-income
countries identify health burden risk associated with breast
feeding practice in their particular regions. A cut-off value
for Rs therefore provides a critical measure which can help
regions identify at risk populations and therefore target
areas where appropriate public health measures may need
to be introduced. The next stage of this global health
project is to identify a simpler DTM design that could be
conducted more readily by field workers across many
diverse regions.
Conclusions
A nonlinear hierarchical model within a Bayesian frame-
work was successfully developed for the description of
deuterium oxide kinetics in exclusively breastfeeding
mother–infant pairs. A cut-off value for a biomarker was
determined that could be used for distinguishing the
exclusivity of breastfeeding practice. The cut-off could be
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used to categorize any new cohort of mother–infant pairs as
EBF or non-EBF group.
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Appendix 1: Rs model development
To calculate the Rs, we need to consider the mass balance
of water for the infant. The schematic in Fig. 5 represents
the mass balance model structure for infant compartment
on total water.
According to the rule of mass balance,
Accumulation ¼ input  output  water for growth
ðA1:1Þ
In terms of water (w), we have,
dw=dt ¼ ðCLmb þ Rm þ Rs þ RaÞ  Rc boð Þ þ Rg
  ðA1:2Þ
where dw=dt is the rate of accumulation of water; Rm is the
intake rate of water metabolised from protein, fat, and
carbohydrate in breastmilk (units: L/day); Rs is the ingested
water intake rate from sources other than breastmilk (units:
L/day); Ra is the water intake rate from absorption of
atmospheric water by lungs and skin (units: L/day);
ðCLmb þ Rm þ Rs þ RaÞ is the total water input rate to the
infant (units: L/day); Rc boð Þ is the total water output from
the infant, i.e. flow from the infant to the outside, which
includes water lost as urine, sweat, in faeces and in breath,
including a correction for isotopic fractionation (discussed
in the next subsection) (units: L/day); Rg: is the water that
is converted by the infant into permanent tissues due to
growth (units: L/day).
At this stage, we consider that no water is accumulated
in the infant over than by growth (see Assumption 1).
Assumption 1 The infant’s compartment is considered in
steady state. Total flow into the compartment is equal to
total flow out of the compartment.
Therefore, we can rearrange Eq. (A1.2) to solve for the
water intake from sources other than breastmilk.
Rs ¼ RcðboÞ þ Rg  CLmb  Rm  Ra ðA1:3Þ
The statistical models used to calculate RcðboÞ, Rg, Rm
and Ra are presented as below. NB, the value of CLmb is
part of the structural model for which the posterior distri-
bution is estimated.
Rm: intake rate of water metabolised
from protein, fat, and carbohydrate in breastmilk
Human breastmilk comprises free water, protein, fat, and
carbohydrate. Water is also produced in the infant by
metabolising the protein, fat, and carbohydrate contained in
breastmilk. In order to calculate the metabolised water
intake rate (Rm, units: L/day), we need to know, (1) the
human milk composition (i.e. the proportion of free water,
protein, fat, and carbohydrate in human milk), (2) the total
mass of breastmilk intake per day (M, units: kg/day), and
(3) the mass of water produced by metabolising, e.g. 1 g of
protein in human milk.
Prior information is used on the human milk composi-
tion. Gidrewicz and Fenton [30] conducted a systematic
review and meta-analysis of the nutrient content of preterm
and term breastmilk, with all values for fat limited to 24-h
breastmilk collections. Studies conducted in low income
countries were excluded. As the infants recruited in our
study were full-term (37–42 weeks gestation), the compo-
sition of full-term breastmilk was used in the analysis.
Notice here that the breastmilk composition varies with
prematurity and postnatal age [30]. The breastmilk com-
position applied in this study is based on data from day 4 to
week 12 of lactation and are presented in Table 2.
Input Output
Accumulation
Consumption
Infant Compartment
H2O
Fig. 5 Mass balance model structure of water in infant’s
compartment
Table 2 The weighted mean and standard error (SE) for human milk
composition (g/100 g human milk)
Protein Fat Lactose Free water
Weighted mean 1.0 3.4 6.7 88.9
SE of weighted mean 0.007 0.092 0.092 0.13
The data values are from the meta-analysis of the nutrient content of
breastmilk reported by Gidrewicz and Fenton [30]
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To calculate the total breastmilk intake mass M, we use
CLmb divided by free water proportion in breastmilk (see
Assumption 2), which in this case is 0.889 (SE = 0.0013).
Assumption 2 The generally assumed water content of
milk is sufficiently precise and accurate to estimate M,
consequently to allow for an unbiased and precise estimate
of Rs.
The formula to calculate M is given in Eq. (A1.4). Here
we apply a density of water of 1 kg/L.
M ðkg=dayÞ ¼ CLmb= 0:889ðSE; 0:0013Þ½  ðA1:4Þ
The yield of water from 1 g of protein is 0.41 g [31],
from 1 g of fat 1.07 g and from 1 g of carbohydrate 0.55 g
[32]. According to Table 2, 100 g breastmilk contain 1.0 g
protein (SE, 0.007 g), 3.4 g fat (SE, 0.092 g) and 6.7 g
lactose (SE, 0.092 g). Therefore, water produced in the
infant from the oxidation of protein, fat, and carbohydrate
in 100 g breastmilk is as presented in Eqs. (A1.5) and
(A1.6). The variable W :F:O represents water from
oxidation.
W :F:O ðmeanÞ ¼ 1:0 0:41þ 3:4 1:07þ 6:7 0:55
¼ 7:733 g
ðA1:5Þ
W :F:O ðSEÞ ¼ ð0:0072  0:41þ 0:0922  1:07þ 0:0922
 0:55Þ0:5
¼ 0:117 g
ðA1:6Þ
This indicates 100 g breastmilk produces 7.733 g water
in average by oxidation process. Consequently, the meta-
bolised water intake rate (Rm) to the infant derived from
breastmilk is given by Eq. (A1.7) (see Assumption 3).
Notice here Rm is in the unit of L/day.
RmðL=dayÞ ¼ ½0:07733ðSE; 0:00117Þ M ðA1:7Þ
Assumption 3 That the generally assumed model for Rm
is sufficiently precise and accurate to estimate Rm, conse-
quently to allow for an unbiased and precise estimate of Rs.
Rg: Water retaining rate for infant’s growth
The total body water (TBW) increases due to the infant’s
growth during the experimental sampling period. A portion
of water (shown as the ‘‘Water for growth’’ component in
Eq. (A1.1) is retained in the infant’s body contributing to
the infant’s growth. The relationship between the increased
TBW and the water retained due to the growth rate Rg is:
RgðL=dayÞ ¼ ðTBWls  TBWfsÞ=ðdayls  dayfsÞ ðA1:8Þ
TBWls and TBWfs represent the infant’s total body water at
the last sampling day (i.e. subscript ls) and at the first
sampling day (i.e. subscript fs), respectively and dayls 
dayfs describes the experimental sampling period, usually
14 days in this study.
TBW is calculated with Eq. (A1.9) [33], according to the
infant’s weight.
lnTBWðLÞ ¼ aþ b lnWTð Þ ðA1:9Þ
where aNð0:427; 0:012Þ, bNð0:963; 0:005Þ.
In this study, the infant’s weight was measured at the
first sampling day (dayfsÞ and the last sampling day (daylsÞ.
TBWls and TBWfs can be calculated with Eq. (A1.9). Thus
Rg can be calculated with Eq. (A1.8) (see Assumption 4).
Assumption 4 That the current equations for TBW are
sufficient to describe Rg and provide an unbiased and
precise estimate of Rs.
Since neither the volume of distribution of the infant
(Vb), nor the fraction of D2O that cross via breastmilk are
identifiable, calculation of Vb based on prior work is nee-
ded. In this study, Vb is calculated based on the infant’s
TBW . To do so, correction for non-aqueous isotopic
exchange is necessary and Vb is assumed to be 4.1% larger
than TBW [11]. Therefore, the infant’s volume of distri-
bution is calculated with Eq. (A1.10) at dayfs and at dayls.
Vb is assumed to change linearly with time due to growth,
thus Vb at other sampling times can be calculated (see
Assumption 5).
VbðLÞ ¼ 1:041 TBW ðA1:10Þ
Assumption 5 That the current equation and method for
calculating Vb are sufficient to provide an unbiased and
precise estimate of Rs.
RcðboÞ: total infant’s water output rate
after isotopic fractionation correction
The D2O DTM technique uses deuterium as a tracer for
describing water kinetics. Since D2O is not identical to
H2O with respect to its physical properties, deuterium is
lost from body water via breath and insensible routes via
the skin (transdermal evaporation) more slowly than light
water. This phenomenon is called isotopic fractionation.
Therefore, a rectification for non-equivalence of insensible
loss of heavy vs light water is needed. Total water output
from the infant, i.e. flow from the infant to the outside
(CLbo) must be corrected for isotopic fractionation. The
results for the hydrogen isotope fractionation factor
a1v Dð Þ from most of the literature were regressed to the
equation [34] as:
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3
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 
 1620:1:8 T
2
106
 
þ 794:84 T
103
 
 161:04
þ 2:9992 10
9
T3
 
ðA1:11Þ
Equation (A1.11) is described as valid from the freezing
temperature of water (273.15 K) to the critical temperature
(647.25 K) within ± 1.2(1r) (n = 157); T is temperature
in Kelvin (K).
A healthy infant’s rectal temperature is considered
between 36.6 and 38 C from various medical information
guidance sources [35, 36]. According to Eq. (A1.11), the
isotopic fractionation factor for deuterium between water
vapour and water liquid is between 0.937 at 36.6 C and
0.938 at 38 C. Since the infant’s rectal temperature is
unknown in this study, we approximate the mean frac-
tionation factor is distributed uniformly over the range
[0.937–0.938]. The fractionation rate of infant’s water
output has been estimated [25] where 85% of the water
output is not fractionated and that the remaining 15% is
fractionated. The correction factor is therefore
0.85 ? (0.937–0.938) 9 0.15, which is 0.99055–0.9907.
Due to the narrow range of the correction factor, it is
treated as a constant 0.9906, Rc boð Þ, and is shown in
Eq. (A1.12) (see Assumption 6).
Rc boð ÞðL=dayÞ ¼ CLbo=0:9906 ðA1:12Þ
Assumption 6 That the current rectification method for
differentiating insensible loss of deuterium compared to
light water can be characterised by Eq. (A1.12) and is
sufficient to provide an unbiased and precise estimate of Rs.
Ra: Absorption of atmospheric water by lungs
and skin
The final component in the calculation of Rs requires
accounting for the water intake rate from absorption of
atmospheric water by the lungs and skin, as Ra. It has been
found that the water intake by absorption is proportional to
the total water intake, and in that work [26] 21 healthy full-
term formula milk fed infants in Cambridge, UK, at
12 weeks of age provided data on both total water intake
and water absorption. Summary data are provided in
Table 3.
As the total water input is equal to total water output
Rc boð Þ plus water for growth Rg, Ra is given by Eq. (A1.13)
(see Assumption 7).
RaðL=dayÞ ¼ 0:063 SE; 0:017ð Þ½   Rc boð Þ þ Rg
 
ðA1:13Þ
Assumption 7 That the estimate of the proportion of non-
oral water intake can be accurately characterised by
Eq. (A1.13) and is sufficient to provide an unbiased and
precise estimate of Rs.
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